Pharmaceutical Industry White Papers
In case you have not noticed, there have been some massive changes in the pharma services industry over the past six months: mergers, acquisitions, more mergers, venture capital/ private equity buy-outs, capital infusions, and even more mergers. What was not too long ago a group of top 10 CROs has quickly been cut to 6 with inVentiv purchasing i3 Pharma Services and PharmaNet and INC Research purchasing Kendle. So now what do we talk about as an industry? What do CROs do next? What does Pharma do about it?
Six Questions to Ask About Your Market Research
Within our “Six Questions to Ask About Your Market Research” white paper, ISR examines 6 questions you should ask in order to ensure you are getting the value you expect. ISR also provides suggestions around “alternative” practices/ approaches that buyers of market research should be on the lookout for.
In this follow-on to our CRO Quality Benchmarking Report, we summarize biotech industry executives' perspectives on the changesin the industry, it's health, and it's future.
Patient and Investigator Recruitment White Paper
“The industry needs a 360-degree assessment of the performance, drivers, motivations, hesitations, and leading edge techniques of patients, investigators, pharmaceutical companies, and pharmaceutical service organizations. Delays in patient recruitment not only have monetary impacts, but they have patient well-being impacts as well.”
CRO Differentiation Whitepaper
The biopharmaceutical industry is becoming increasingly dependent on contract research organizations (CROs) for their clinical development. However, the selection of a service provider partner is still a “risky” proposition given the lack of clearly differentiated CRO service offerings.